跳至主要内容
临床试验/NCT05201235
NCT05201235已完成不适用

Maevad - Mobilisation Active de l'Empan Visuo-Attentionel Pour la Dyslexie

Humans Matter110 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2022年1月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Humans Matter
入组人数
74
试验地点
110
主要终点
Reading speed

研究概览

简要总结

The aim of the study is to evaluate the efficiency of the medical device MAEVAD in improving the reading skills of children with dyslexia.

详细描述

MAEVAD is a digital therapy specifically designed to improve the visual attention (VA) span of children with dyslexia. Dyslexia is characterized by a specific and significant impairment in reading and/or writing production and spelling. Some profiles of children with dyslexia show a deficit in VA span, characterized by a decrease in the number of distinct visual elements that can be processed simultaneously. VA span plays a critical role in the acquisition of reading skills and specific knowledge of word spelling. Brain regions involved in visual-attentional skills are under-activated in dyslexic children with VA deficits and can be reactivated following specific and intensive VA span training.

In this study 150 children with dyslexia will be randomized in tow groups. On the first group children will be trained first with MAEVAD then with a control training that does not stimulate the VA span. On contrary, on the second group children will first perform the control training and then MAEVAD.

For each intervention the sessions will lasts 15 minutes. 5 sessions are planned per weeks for 6 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

The training will be performed at home. The investigators/evaluators will send a download link of the therapy to the patient's parents without knowing which therapy it corresponds to.

入排标准

年龄范围
8 Years 至 11 Years(Child)
性别
All
接受健康志愿者

入选标准

  • School children from CE2 to CM2, aged 8 to 11 years
  • Dyslexic children with a VA span deficit (composite visual-attention span below the fifteenth percentile and a letter threshold above or equal to the twentieth percentile with the - - - Evadys(c) battery)
  • Established diagnosis of Dyslexia
  • Children whose parents/legal guardians have signed informed consent and agree to participate in the study
  • Children whose first language is French or who have been educated in French since kindergarten
  • Raven's Progressive Matrices score above the 20th percentile or a WISC IV or V Verbal Comprehension Index or WISC IV or V Perceptual/Fluid Reasoning Index above 85 or documented/objectifiable absence of intellectual deficit
  • Child with access to a computer
  • Normal or corrected vision and audition

排除标准

  • Attention deficit hyperactivity disorder,dysphasia, dyspraxia, Autism Spectrum Disorder
  • Neurological disorders
  • Children who have missed 3 months or more of school in the current or previous year (excluding lockdown)
  • Children not affiliated to a social security scheme

研究组 & 干预措施

MAEVAD - DeCaLigne

Experimental

The experimental group will first receive MAEVAD then the control therapy

干预措施: MAEVAD (Device)

DeCaLigne - MAEVAD

Placebo Comparator

The control group will first receive the control therapy then MAEVAD

干预措施: DeCaLigne (Device)

结局指标

主要结局

Reading speed

时间窗: 26 weeks to baseline

Measure of reding time from texts of 122 to 152 words

次要结局

  • Orthographic skills(26 weeks to baseline)
  • Reading skills(26 weeks to baseline)
  • VA Span(26 weeks to baseline)
  • Phonologic skills(26 weeks to baseline)
  • Mathematical skills(18 weeks to baseline)

研究者

发起方
Humans Matter
申办方类型
Industry
责任方
Sponsor

研究点 (110)

Loading locations...

相似试验